Macular ganglion cell -inner plexiform layer thickness is associated with clinical progression in mild cognitive impairment and alzheimers disease

PLoS ONE

Volumn 11, Issue 9, 2016, Pages

  Choi, Seong Hye ^a   Park, Sang Jun ^a   Kim, Na Rae ^a  

^a Inha University School of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ALZHEIMER DISEASE; ARTICLE; CLINICAL DEMENTIA RATING SCALE SUM OF BOXES; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE CONTROL; DISEASE COURSE; DISEASE MARKER; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEMORY DISORDER; MILD COGNITIVE IMPAIRMENT; NEUROPSYCHOLOGICAL TEST; RATING SCALE; RETINA NERVE CELL; RETINAL INNER PLEXIFORM LAYER; RETINAL NERVE FIBER LAYER THICKNESS; SCORING SYSTEM; SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHY; CASE CONTROL STUDY; COGNITIVE DEFECT; DIAGNOSTIC IMAGING; MEMORY; MIDDLE AGED; NERVE FIBER; OPTIC NERVE; OPTICAL COHERENCE TOMOGRAPHY; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; RETINA GANGLION CELL; VERY ELDERLY;

BIOLOGICAL MARKER;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; BIOMARKERS; CASE-CONTROL STUDIES; COGNITIVE DYSFUNCTION; DISEASE PROGRESSION; FEMALE; HUMANS; MALE; MEMORY; MIDDLE AGED; NERVE FIBERS; OPTIC NERVE; RETINAL GANGLION CELLS; TOMOGRAPHY, OPTICAL COHERENCE;

EID: 84991338038     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0162202     Document Type: Article

References (38)

1. Querfurth HW, LaFerla FM. Alzheimer's disease. The New England journal of medicine. 2010; 362 (4):329-44. doi: 10.1056/NEJMra0909142 PMID: 20107219.
2. Sperling RA, Aisen PS, Beckett LA, Bennett DA, Craft S, Fagan AM, et al. Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimer's & dementia: the journal of the Alzheimer's Association. 2011; 7(3):280-92. doi: 10.1016/j.jalz.2011.03.003 PMID: 21514248; PubMed Central PMCID: PMC3220946.
3. Albert MS, DeKosky ST, Dickson D, Dubois B, Feldman HH, Fox NC, et al. The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimer's & dementia: the journal of the Alzheimer's Association. 2011; 7(3):270-9. doi: 10.1016/j.jalz.2011.03.008 PMID: 21514249; PubMed Central PMCID: PMC3312027.
4. Petersen RC, Doody R, Kurz A, Mohs RC, Morris JC, Rabins PV, et al. Current concepts in mild cognitive impairment. Archives of neurology. 2001; 58(12):1985-92. PMID: 11735772.
5. Clark CM, Pontecorvo MJ, Beach TG, Bedell BJ, Coleman RE, Doraiswamy PM, et al. Cerebral PET with florbetapir compared with neuropathology at autopsy for detection of neuritic amyloid-beta plaques: a prospective cohort study. The Lancet Neurology. 2012; 11(8):669-78. doi: 10.1016/S1474-4422(12)70142-4 PMID: 22749065.
6. Kim HJ, Park KW, Kim TE, Im JY, Shin HS, Kim S, et al. Elevation of the Plasma Abeta40/Abeta42 Ratio as a Diagnostic Marker of Sporadic Early-Onset Alzheimer's Disease. J Alzheimers Dis. 2015; 48 (4):1043-50. doi: 10.3233/JAD-143018 PMID: 26444752.
7. Kirby E, Bandelow S, Hogervorst E. Visual impairment in Alzheimer's disease: a critical review. J Alzheimers Dis. 2010; 21(1):15-34. doi: 10.3233/JAD-2010-080785 PMID: 20182034.
8. Sadun AA, Bassi CJ. Optic nerve damage in Alzheimer's disease. Ophthalmology. 1990; 97(1):9-17. PMID: 2314849.
9. La Morgia C, Ross-Cisneros FN, Koronyo Y, Hannibal J, Gallassi R, Cantalupo G, et al. Melanopsin retinal ganglion cell loss in Alzheimer disease. Ann Neurol. 2016; 79(1):90-109. doi: 10.1002/ana.24548 PMID: 26505992; PubMed Central PMCID: PMC4737313.
10. Hinton DR, Sadun AA, Blanks JC, Miller CA. Optic-nerve degeneration in Alzheimer's disease. The New England journal of medicine. 1986; 315(8):485-7. doi: 10.1056/NEJM198608213150804 PMID: 3736630.
11. Paquet C, Boissonnot M, Roger F, Dighiero P, Gil R, Hugon J. Abnormal retinal thickness in patients with mild cognitive impairment and Alzheimer's disease. Neurosci Lett. 2007; 420(2):97-9. Epub 2007/ 06/05. S0304-3940(07)00249-2 [pii] doi: 10.1016/j.neulet.2007.02.090 PMID: 17543991.
12. Marziani E, Pomati S, Ramolfo P, Cigada M, Giani A, Mariani C, et al. Evaluation of retinal nerve fiber layer and ganglion cell layer thickness in Alzheimer's disease using spectral-domain optical coherence tomography. Invest Ophthalmol Vis Sci. 2013; 54(9):5953-8. doi: 10.1167/iovs.13-12046 PMID: 23920375.
13. Garcia-Martin ES, Rojas B, Ramirez AI, de Hoz R, Salazar JJ, Yubero R, et al. Macular thickness as a potential biomarker of mild Alzheimer's disease. Ophthalmology. 2014; 121(5):1149-51 e3. doi: 10. 1016/j.ophtha.2013.12.023 PMID: 24656417.
14. Bayhan HA, Aslan Bayhan S, Celikbilek A, Tanik N, Gurdal C. Evaluation of the chorioretinal thickness changes in Alzheimer's disease using spectral-domain optical coherence tomography. Clinical & experimental ophthalmology. 2015; 43(2):145-51. doi: 10.1111/ceo.12386 PMID: 24995484.
15. Gao L, Liu Y, Li X, Bai Q, Liu P. Abnormal retinal nerve fiber layer thickness and macula lutea in patients with mild cognitive impairment and Alzheimer's disease. Archives of gerontology and geriatrics. 2015; 60(1):162-7. doi: 10.1016/j.archger.2014.10.011 PMID: 25459918.
16. Coppola G, Di Renzo A, Ziccardi L, Martelli F, Fadda A, Manni G, et al. Optical Coherence Tomography in Alzheimer's Disease: A Meta-Analysis. PLoS One. 2015; 10(8):e0134750. doi: 10.1371/journal. pone.0134750 PMID: 26252902; PubMed Central PMCID: PMC4529274.
17. Cheung CY, Ong YT, Hilal S, Ikram MK, Low S, Ong YL, et al. Retinal ganglion cell analysis using highdefinition optical coherence tomography in patients with mild cognitive impairment and Alzheimer's disease. J Alzheimers Dis. 2015; 45(1):45-56. doi: 10.3233/JAD-141659 PMID: 25428254.
18. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. Washinton DC.: American Medical Association; 1994.
19. McKhann GM, Knopman DS, Chertkow H, Hyman BT, Jack CR Jr., Kawas CH, et al. The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement. 2011; 7(3):263-9. Epub 2011/04/26. S1552-5260(11)00101-4 [pii] doi: 10.1016/j.jalz.2011.03.005 PMID: 21514250; PubMed Central PMCID: PMC3312024.
20. Ahn HJ, Chin J, Park A, Lee BH, Suh MK, Seo SW, et al. Seoul Neuropsychological Screening Battery-Dementia Version (SNSB-D): A Useful Tool for Assessing and Monitoring Cognitive Impairments in Dementia Patients. Journal of Korean medical science. 2010; 25(7):1071-6. doi: 10.3346/jkms.2010. 25.7.1071 WOS:000279671100015. PMID: 20592901
21. Choi SH, Lee BH, Kim S, Hahm DS, Jeong JH, Yoon SJ, et al. Interchanging scores between Clinical Dementia Rating scale and Global Deterioration Scale. Alz Dis Assoc Dis. 2003; 17(2):98-105. doi: 10. 1097/00002093-200304000-00008. WOS:000183730100008.
22. Han C, Jo SA, Jo I, Kim E, Park MH, Kan Y. An adaptation of the Korean mini-mental state examination (K-MMSE) in elderly Koreans: Demographic influence and population-based norms (the AGE study). Archives of gerontology and geriatrics. 2008; 47(3):302-10. doi: 10.1016/j.archger.2007.08.012 WOS:000260289800002. PMID: 17936377
23. Christensen KJ, Multhaup KS, Nordstrom S, Voss K. A cognitive battery for dementia: Development and measurement characteristics. Psychological Assessment: A Journal of Consulting and Clinical Psychology. 1991; 3(2):168-74.
24. Mwanza JC, Durbin MK, Budenz DL, Sayyad FE, Chang RT, Neelakantan A, et al. Glaucoma diagnostic accuracy of ganglion cell-inner plexiform layer thickness: comparison with nerve fiber layer and optic nerve head. Ophthalmology. 2012; 119(6):1151-8. doi: 10.1016/j.ophtha.2011.12.014 PMID: 22365056.
25. Choi SH, Kim S, Han SH, Na DL, Kim DK, Cheong HK, et al. Neurologic signs in relation to cognitive function in subcortical ischemic vascular dementia: a CREDOS (Clinical Research Center for Dementia of South Korea) study. Neurol Sci. 2012; 33(4):839-46. doi: 10.1007/s10072-011-0845-4 WOS:000306551000016. PMID: 22068220
26. Iseri PK, Altinas O, Tokay T, Yuksel N. Relationship between cognitive impairment and retinal morphological and visual functional abnormalities in Alzheimer disease. Journal of neuro-ophthalmology: the official journal of the North American Neuro-Ophthalmology Society. 2006; 26(1):18-24. doi: 10.1097/ 01.wno.0000204645.56873.26 PMID: 16518161.
27. Belleville S, Fouquet C, Duchesne S, Collins DL, Hudon C. Detecting early preclinical Alzheimer's disease via cognition, neuropsychiatry, and neuroimaging: qualitative review and recommendations for testing. J Alzheimers Dis. 2014; 42 Suppl 4:S375-82. doi: 10.3233/JAD-141470 PMID: 25190629.
28. Dubois B, Feldman HH, Jacova C, Dekosky ST, Barberger-Gateau P, Cummings J, et al. Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria. Lancet Neurol. 2007; 6(8):734-46. doi: 10.1016/S1474-4422(07)70178-3 PMID: 17616482.
29. Liu M, Duggan J, Salt TE, Cordeiro MF. Dendritic changes in visual pathways in glaucoma and other neurodegenerative conditions. Exp Eye Res. 2011; 92(4):244-50. Epub 2011/02/12. S0014-4835(11) 00034-0 [pii] doi: 10.1016/j.exer.2011.01.014 PMID: 21310146.
30. Blanks JC, Hinton DR, Sadun AA, Miller CA. Retinal ganglion cell degeneration in Alzheimer's disease. Brain Res. 1989; 501(2):364-72. Epub 1989/11/06. 0006-8993(89)90653-7 [pii]. PMID: 2819446.
31. Gasparini L, Crowther RA, Martin KR, Berg N, Coleman M, Goedert M, et al. Tau inclusions in retinal ganglion cells of human P301S tau transgenic mice: effects on axonal viability. Neurobiol Aging. 2011; 32(3):419-33. Epub 2009/04/10. S0197-4580(09)00096-7 [pii] doi: 10.1016/j.neurobiolaging.2009.03. 002 PMID: 19356824.
32. Parnell M, Guo L, Abdi M, Cordeiro MF. Ocular manifestations of Alzheimer's disease in animal models. Int J Alzheimers Dis. 2012; 2012:786494. Epub 2012/06/06. doi: 10.1155/2012/786494 PMID: 22666623; PubMed Central PMCID: PMC3362039.
33. Berisha F, Feke GT, Trempe CL, McMeel JW, Schepens CL. Retinal abnormalities in early Alzheimer's disease. Invest Ophthalmol Vis Sci. 2007; 48(5):2285-9. doi: 10.1167/iovs.06-1029 PMID: 17460292.
34. Curcio CA, Allen KA. Topography of ganglion cells in human retina. J Comp Neurol. 1990; 300(1):5-25. Epub 1990/10/01. doi: 10.1002/cne.903000103 PMID: 2229487.
35. Blanks JC, Torigoe Y, Hinton DR, Blanks RH. Retinal pathology in Alzheimer's disease. I. Ganglion cell loss in foveal/parafoveal retina. Neurobiol Aging. 1996; 17(3):377-84. Epub 1996/05/01. 0197458096000103 [pii]. PMID: 8725899.
36. Blanks JC, Schmidt SY, Torigoe Y, Porrello KV, Hinton DR, Blanks RH. Retinal pathology in Alzheimer's disease. II. Regional neuron loss and glial changes in GCL. Neurobiol Aging. 1996; 17(3):385-95. Epub 1996/05/01. 0197458096000097 [pii]. PMID: 8725900.
37. Ning A, Cui J, To E, Ashe KH, Matsubara J. Amyloid-beta deposits lead to retinal degeneration in a mouse model of Alzheimer disease. Investigative ophthalmology & visual science. 2008; 49(11):5136-43. doi: 10.1167/iovs.08-1849 PMID: 18566467; PubMed Central PMCID: PMC3947384.
38. Williams PA, Thirgood RA, Oliphant H, Frizzati A, Littlewood E, Votruba M, et al. Retinal ganglion cell dendritic degeneration in a mouse model of Alzheimer's disease. Neurobiol Aging. 2013; 34(7):1799-806. Epub 2013/03/08. S0197-4580(13)00024-9 [pii] doi: 10.1016/j.neurobiolaging.2013.01.006 PMID: 23465714.